Expectations trend
FY2028 · fiscal year ending 2028-10-04 · fmp
$5.36 → $6.15 · observed estimates
Kulicke and Soffa Industries, Inc. (KLIC)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-04
$59.83-12.58%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
5.36 → 6.15 EPS · FY ending Oct 4, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for KLIC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain dividend payout near $0.20 per share | Dividend payout remains steady at about $0.20 per share. | Intact | dividend per share falls below $0.20 | Dividend per share: $0.20 per share FY2026-Q2; GAAP. Published target: ~$0.20 per share. The target does not explicitly identify fiscal versus calendar quarters. May 7, 20260.205 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-10-04 · fmp
$5.36 → $6.15 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
KLIC is an improving semiconductor equipment business with a cyclical, execution-sensitive profile rather than a proven durable compounder. The long-term thesis is intact, supported by stronger recent results, though the evidence snapshot rates earnings quality as fragile and risk as elevated.
The valuation evidence calls KLIC cheap versus peers, while the expectations gap is negative, suggesting expectations are not demanding. The pricing assessment is tagged justified, with low fragility, so the evidence does not point to a clear mismatch between expectations and business risk.
Near-term results have improved: revenue rose across the last three reported quarters, and operating income and margins strengthened. Management is on track with its stated growth, margin, and dividend priorities, but recent industry misses and a deep miss in KLIC’s history keep execution risk relevant; the CEO transition adds uncertainty.
The near-term downside scenario is a guidance cut on the next call, which would matter given the history of estimates being revised lower after weak guidance. Over the multi-year view, continued revenue and margin progress is central; easier interest rates or stabilization among major technology companies could support the sector backdrop, while the evidence does not establish that either will occur.
For the next one to three years, KLIC’s thesis rests on turning strong recent growth and margin improvement into consistent execution despite fragile earnings quality and elevated risk. The business setup remains intact, but its durability is not yet established. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company guides Q3 revenue around $310M and EPS near $1.00, showing progress. |
| Intact |
| EPS falls below $0.9 in Q3 2026 |
Diluted EPS: $1.07 per share FY2026-Q3; GAAP. Published target: ~$1.00. The target does not explicitly identify fiscal versus calendar quarters. Aug 6, 20261.07 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve operating income to at least $38.6M in Q2 2026 | Profit improved with operating income rising from $17.8M to $38.6M in the same period. | Improving | operating income falls below $17.8M in Q3 2026 | Operating income: $68.266M FY2026-Q3; GAAP. Published target: >= $38.6M. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Aug 6, 202668,266,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Sustain revenue growth near $310M in Q3 2026 | A primary condition in Kulicke and Soffa Industries, Inc.'s published investment case. The stated target is ~$310M. | Intact | revenue falls below $290M in Q3 2026 | Revenue: $330.409M FY2026-Q3; GAAP. Published target: ~$310M. The target does not explicitly identify fiscal versus calendar quarters. Aug 6, 2026330,409,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.46B → $1.59B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-10-05 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-06 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-07 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-08 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-09 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-10 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-11 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-12 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-13 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-14 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-15 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-16 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-17 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-18 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-19 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-20 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-21 | $5.36 | $1,461,650,000 | 1 / 2 |
| 2026-10-22 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-10-23 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-10-24 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-10-25 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-10-26 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-10-27 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-10-28 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-10-29 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-10-30 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-10-31 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-11-01 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-11-02 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-11-03 | $6.15 | $1,594,750,000 | 1 / 2 |
| 2026-11-04 | $6.15 | $1,594,750,000 | 1 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 18, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.